Disease Info Card

Hypogonadotropic Hypogonadism

Information about Hypogonadotropic Hypogonadism: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Hypogonadotropic Hypogonadism

Most recent studies have shown that Hypogonadotropic Hypogonadism shares some biological mechanisms with adrenal-gland-hypofunction, amenorrhea, anosmia, congenital-absence-of-adrenal-gland, congenital-hypoplasia-of-adrenal-gland, cryptorchidism, delayed-puberty, diabetes-mellitus, hyperprolactinemia, hypogonadism, hypopituitarism, hypoplasia, idiopathic-hypogonadotropic-hypogonadism, infertility, kallmann-syndrome, male-infertility, neoplasms, obesity, olfaction-disorders, pituitary-diseases.

Among the many pathways, these few ones have gauged particular interests from scientists studying Hypogonadotropic Hypogonadism, and have been seen in publications frequently: Aging, Excretion, Fertilization, Gonadotropin Secretion, Growth Hormone Secretion, Hormone Secretion, Insemination, Localization, Menarche, Menopause, Menstruation, Ovulation, Pathogenesis, Pigmentation, Prolactin Secretion, Secretion, Sex Determination, Sperm Motility, Spermatogenesis, Testosterone Secretion

Quite a number of genes have been found to play important roles in Hypogonadotropic Hypogonadism, such as BRD2, FGFR1, GGH, GH1, GNRH1, GNRHR, HFE, IHH, KISS1, KISS1R, NR0B1, NR5A1, PLOD1, POMC, PRL, SHBG, TRH. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.